United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

hameln pharma ltd - midazolam hydrochloride - solution for infusion - 2mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

hameln pharma ltd - midazolam hydrochloride - solution for infusion - 1mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

martindale pharmaceuticals ltd - midazolam hydrochloride - solution for infusion - 2mg/1ml

Australia - English - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - ganciclovir sodium -

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - promethazine hydrochloride -

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - promethazine hydrochloride 25 mg/ml - solution for injection - 50 mg/2ml - active: promethazine hydrochloride 25 mg/ml excipient: glacial acetic acid sodium acetate trihydrate sodium edetate sodium metabisulfite water for injection - dbl™ promethazine hydrochloride injection bp is indicated for the following conditions: treatment of allergic reactions such as: uncomplicated allergic conditions of the immediate type, eg. pruritus, urticaria and angioedema, when oraltherapy is impossible or contraindicated treatment and prevention of vomiting including: motion sickness; drug induced nausea; prevention and control of nausea and vomiting associated with certain types of anaesthesia and surgery, such as procedures with a high incidence of postoperative vomiting (eg. gynaecological surgery, strabismus or middle ear surgery, and electroconvulsive therapy); in patients with a past history of motion sickness or post operative vomiting; and in patients in whom avoidance of vomiting is crucial (eg. neurosurgery and eye surgery); promethazine has sedative effects and it is also used in: preoperative, postoperative and obstetric (during labour) sedation.

New Zealand - English - Medsafe (Medicines Safety Authority)

obex medical ltd - meglumine ioxaglate 39.3%{relative} (gives 320mg iodine/ml); sodium ioxaglate 19.65%{relative} - solution for injection - 320 mg/ml - active: meglumine ioxaglate 39.3%{relative} (gives 320mg iodine/ml) sodium ioxaglate 19.65%{relative} excipient: sodium calcium edetate, hydrate water for injection - low osmolar x-ray contrast medium for the opacification of the vascular system, urinary tract, joints and female genital tract. hysterosalpingography

Ireland - English - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - folinic acid - solution for inj/inf - 10 mg/ml - detoxifying agents for antineoplastic treatment

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - furosemide - solution for injection - 20 mg/2ml - furosemide

Ireland - English - HPRA (Health Products Regulatory Authority)

claris lifesciences (uk) limited - furosemide - solution for injection - 10 mg/ml - sulfonamides, plain